Status:
TERMINATED
Pharmacokinetic of levobupivacaïne After Sciatic Nerve Block in Children
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Surgical Pathology of the Leg or the Foot.
Eligibility:
All Genders
6-12 years
Phase:
PHASE3
Brief Summary
Levobupivacaïne (Chirocaine®) is a new local anaesthetic recently marketed in France. The goal of this prospective work is to study the pharmacokinetic aspect of this drug after injection around the s...
Detailed Description
The originality of this work is to call upon a modelling of pharmacokinetic by using the principle of the pharmacology of population. This work also proposes to appreciate a dynamic aspect since data...
Eligibility Criteria
Inclusion
- Surgical pathology of the leg or the foot with garot tyre of thigh
- Age included between 6 months and 12 years
- Status ASA I or II
Exclusion
- Bilateral or one-sided surgical gesture realized without garot tyre
- Cutaneous infection in the point of draining
- Clinical confusion of the coagulation
- Allergy informed in the local anesthesics of amino-acid class
- Evolutionary neurological pathology of the operated limb
- Renal, respiratory, cardiac or hepatic insufficiency.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00682344
Start Date
January 1 2008
End Date
January 1 2012
Last Update
August 28 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital de la Timone - Pôle d'anesthésie réanimation pédiatrique
Marseille, France, 13005